RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.93B
AUM Growth
+$243M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$95M
2
+$77.3M
3
+$72.9M
4
PCVX icon
Vaxcyte
PCVX
+$61.2M
5
ACRV icon
Acrivon Therapeutics
ACRV
+$55.4M

Top Sells

1
+$180M
2
+$112M
3
+$74.6M
4
RLMD icon
Relmada Therapeutics
RLMD
+$74M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.5M

Sector Composition

1 Healthcare 99.36%
2 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$55.4M 1.12%
+4,810,508
27
$55M 1.12%
7,236,454
28
$52.8M 1.07%
9,770,773
29
$52.6M 1.07%
958,980
30
$48.3M 0.98%
13,150,849
31
$47.6M 0.97%
4,898,373
32
$47.4M 0.96%
5,963,565
33
$47.1M 0.96%
2,407,149
+300,000
34
$46.8M 0.95%
7,805,129
35
$43.6M 0.88%
+4,000,000
36
$38.7M 0.78%
3,052,796
37
$36M 0.73%
3,773,517
38
$32.3M 0.66%
4,397,368
+40,736
39
$31.3M 0.63%
12,930,711
-17,195,588
40
$30.5M 0.62%
2,971,231
+198,000
41
$29.4M 0.6%
1,760,019
42
$26M 0.53%
4,264,144
43
$25.7M 0.52%
880,000
44
$25.7M 0.52%
+3,009,678
45
$19.6M 0.4%
+1,400,001
46
$18.4M 0.37%
3,426,286
+2,601,761
47
$15M 0.3%
1,500,000
48
$13.3M 0.27%
+1,856,904
49
$13.3M 0.27%
+812,681
50
$12.2M 0.25%
6,067,483
+4,465,474
1
2
3 4